Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities - Summary - MDSpire

Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

  • By

  • Lifei Xu

  • Bin Wang

  • Wenwei Li

  • Xiandan Luo

  • Lixia Wang

  • Yi Zheng

  • May 13, 2026

  • 0 min

Share

Objective:

Emphasize the significance of PTMs in retinoblastoma.

Key Findings:
  • Add details on the implications of less studied PTMs.
Interpretation:

Strengthen the connection to clinical implications.

Limitations:
  • Specify which PTMs are under-researched.
Conclusion:

Reiterate the potential impact on patient outcomes.

Original Source(s)

Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

  • by Lifei Xu, Bin Wang, Wenwei Li, Xiandan Luo, Lixia Wang, Yi Zheng

  • May 13, 2026

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate